Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free LYEL Stock Alerts

Lyell Immunopharma (LYEL) Institutional Ownership

Lyell Immunopharma logo
$14.71 +0.50 (+3.52%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$14.73 +0.02 (+0.14%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Lyell Immunopharma (NASDAQ:LYEL)

Current
Institutional Ownership
Percentage
66.05%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$134.10M
Number of
Institutional Sellers
(last 12 months)
21
Total
Institutional Outflows
(last 12 months)
$651.96M
Get LYEL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LYEL Institutional Buying and Selling by Quarter

Lyell Immunopharma Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/6/2026 Bank of New York Mellon Corp24,673$347K0.0%N/A0.101%
5/19/2026Bank of America Corp DE33,321$668K0.0%+314.2%0.143%
5/19/2026RBF Capital LLC44,094$885K0.0%-40.9%0.189%
5/14/2026Renaissance Technologies LLC116,411$2.34M0.0%+194.8%0.499%
5/14/2026 Walleye Capital LLC22,207$445K0.0%N/A0.095%
5/7/2026Dimensional Fund Advisors LP47,888$959K0.0%N/A0.205%
2/19/2026Invesco Ltd.98,649$3.04M0.0%N/A0.464%
2/18/2026venBio Partners LLC337,697$10.39M4.8%-28.7%1.590%
2/18/2026Ikarian Capital LLC41,081$1.26M0.1%-6.2%0.193%
2/18/2026Millennium Management LLC58,651$1.81M0.0%-53.2%0.276%
2/18/2026MWG Caph Ltd1,008,116$31.03M42.9%N/A4.746%
2/18/2026Boothbay Fund Management LLC9,516$293K0.0%-22.2%0.045%
2/17/2026ExodusPoint Capital Management LP8,511$262K0.0%N/A0.040%
2/17/2026RBF Capital LLC74,585$2.30M0.1%-22.0%0.351%
2/16/2026Barclays PLC15,967$491K0.0%+1,239.5%0.075%
2/13/2026Marshall Wace LLP73,315$2.26M0.0%N/A0.345%
2/13/2026Charles Schwab Investment Management Inc.85,423$2.63M0.0%+7.4%0.402%
2/13/2026 State Street Corp51,472$1.58M0.0%+52.5%0.242%
2/12/2026Jane Street Group LLC12,409$382K0.0%N/A0.058%
2/12/2026GSK plc1,512,659$46.56M5.8%N/A7.122%
2/12/2026Renaissance Technologies LLC39,490$1.22M0.0%-38.3%0.186%
2/11/2026BBR Partners LLC6,834$210K0.0%N/A0.032%
2/10/2026Goldman Sachs Group Inc.96,675$2.98M0.0%N/A0.455%
2/9/2026Geode Capital Management LLC162,997$5.02M0.0%+25.1%0.767%
11/17/2025Susquehanna International Group LLP16,159$262K0.0%-27.9%0.076%
11/17/2025Millennium Management LLC125,361$2.04M0.0%+140.0%0.591%
11/17/2025Foresite Capital Management V LLC477,078$7.75M7.1%+17.3%2.248%
11/17/2025Bank of America Corp DE4,679$76K0.0%-80.3%0.022%
11/17/2025Almitas Capital LLC577,807$9.38M2.1%-0.4%2.723%
11/14/2025ARCH Venture Management LLC2,759,072$44.81M9.1%+51.5%14.362%
11/14/2025Two Sigma Investments LP20,827$338K0.0%+107.0%0.108%
11/13/2025Takeda Pharmaceutical Co. Ltd.54,887$891K5.4%+33.3%0.286%
11/7/2025Vanguard Group Inc.779,004$12.65M0.0%+76.0%4.055%
10/14/2025Clarius Group LLC19,958$324K0.0%+4.3%0.104%
8/28/2025 China Universal Asset Management Co. Ltd.2,966$26K0.0%-94.9%0.015%
8/15/2025 Orland Properties Ltd754,698$6.67M2.8%-95.0%3.929%
8/15/2025MWG Management Ltd.1,008,116$8.91M17.2%-95.0%5.248%
8/15/2025HSG Holding Ltd152,299$1.35M0.1%-95.0%0.793%
8/15/2025Boothbay Fund Management LLC12,234$108K0.0%-95.0%0.064%
8/15/2025Bridgeway Capital Management LLC18,000$159K0.0%N/A0.094%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
8/15/2025Bank of America Corp DE23,758$210K0.0%-74.7%0.124%
8/15/2025ARCH Venture Management LLC1,820,634$16.11M5.4%N/A9.478%
8/14/2025Orbimed Advisors LLC51,727$457K0.0%N/A0.335%
8/14/2025Raymond James Financial Inc.7,900$70K0.0%-95.0%0.051%
8/14/2025Canada Pension Plan Investment Board29,411$260K0.0%-95.0%0.190%
8/14/2025The Manufacturers Life Insurance Company 24,419$216K0.0%-95.2%0.158%
8/14/2025RBF Capital LLC100,000$884K0.0%N/A0.647%
8/13/2025Marshall Wace LLP10,580$94K0.0%N/A0.068%
8/13/2025 Walleye Capital LLC29,230$258K0.0%N/A0.189%
8/13/2025Decheng Capital LLC595,466$5.26M1.2%-95.0%3.852%
8/13/2025Invesco Ltd.12,809$113K0.0%-96.6%0.083%
8/12/2025Foresite Capital Management V LLC406,652$3.60M4.5%-95.0%2.630%
8/12/2025Foresite Capital Management IV LLC800,399$7.08M5.7%-95.0%5.177%
8/12/2025JPMorgan Chase & Co.3,369$30K0.0%-98.3%0.022%
8/8/2025Geode Capital Management LLC103,270$913K0.0%-97.7%0.668%
8/8/2025Takeda Pharmaceutical Co. Ltd.41,165$364K1.9%-95.0%0.266%
8/1/2025 Alphabet Inc.293,256$2.59M0.1%-95.0%1.980%
7/28/2025 TD Asset Management Inc50,232$444K0.0%-95.0%0.339%
7/22/2025 Johnson & Johnson41,165$368K0.1%-95.0%0.278%
7/22/2025Clarius Group LLC19,138$169K0.0%-95.2%0.129%
6/27/2025Goldman Sachs Group Inc.358,592$193K0.0%-42.8%2.421%
6/18/2025Voya Investment Management LLC50,329$27K0.0%-4.9%0.340%
5/29/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
5/21/2025Acadian Asset Management LLC660,899$354K0.0%+204.2%0.224%
5/19/2025Jane Street Group LLC64,241$35K0.0%-73.2%0.022%
5/16/2025Goldman Sachs Group Inc.358,592$193K0.0%-42.8%0.121%
5/16/2025Jacobs Levy Equity Management Inc.558,979$301K0.0%-59.6%0.189%
5/16/2025AQR Capital Management LLC174,279$94K0.0%+773.5%0.059%
5/16/2025Almitas Capital LLC2,482,606$1.34M0.4%+136.3%0.841%
5/12/2025Nuveen LLC641,173$345K0.0%N/A0.217%
5/12/2025Invesco Ltd.378,880$204K0.0%-7.0%0.128%
5/9/2025Charles Schwab Investment Management Inc.1,604,676$863K0.0%-2.5%0.543%
4/17/2025Exchange Traded Concepts LLC246,349$133K0.0%+82.4%0.083%
4/8/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
2/19/2025Public Employees Retirement System of Ohio99,307$64K0.0%N/A0.034%
2/17/2025venBio Partners LLC7,102,190$4.55M2.7%N/A2.431%
2/17/2025Two Sigma Investments LP204,501$131K0.0%-15.4%0.070%
2/17/2025Two Sigma Advisers LP306,400$196K0.0%+143.8%0.105%
2/17/2025Nuveen Asset Management LLC641,173$410K0.0%-25.1%0.219%
2/17/2025Orbimed Advisors LLC3,103,623$1.99M0.0%-49.0%1.062%
2/17/2025Millennium Management LLC957,507$613K0.0%+34.8%0.328%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.308,551$197K0.0%+13.4%0.106%
2/17/2025Jacobs Levy Equity Management Inc.1,385,301$887K0.0%N/A0.474%
2/17/2025Graham Capital Management L.P.52,136$33K0.0%N/A0.018%
2/17/2025Foresite Capital Management V LLC8,133,047$5.21M4.3%N/A2.784%
2/17/2025D. E. Shaw & Co. Inc.966,265$618K0.0%+104.4%0.331%
2/17/2025BNP Paribas Financial Markets253,669$162K0.0%N/A0.087%
2/17/2025Almitas Capital LLC1,050,520$672K0.1%N/A0.360%
2/14/2025Jane Street Group LLC239,439$153K0.0%-16.8%0.082%
2/14/2025Northern Trust Corp1,310,224$839K0.0%-3.4%0.448%
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
2/14/2025Decheng Capital LLC11,909,341$7.62M1.6%N/A4.076%
2/14/2025Boothbay Fund Management LLC406,234$260K0.0%+190.4%0.139%
2/14/2025Price T Rowe Associates Inc. MD6,910,749$4.42M0.0%-6.0%2.365%
2/14/2025Johnson & Johnson823,317$527K0.1%N/A0.282%
2/13/2025Barclays PLC258,380$165K0.0%+7.4%0.088%
2/13/2025Renaissance Technologies LLC1,612,146$1.03M0.0%+716.7%0.552%
2/13/2025Wells Fargo & Company MN94,320$60K0.0%+27.8%0.032%
2/12/2025RPO LLC66,378$42K0.0%N/A0.023%
2/12/2025Geode Capital Management LLC4,137,264$2.65M0.0%+2.9%1.416%
2/12/2025Takeda Pharmaceutical Co. Ltd.823,317$527K2.0%N/A0.282%


LYEL Institutional Ownership - Frequently Asked Questions

During the previous two years, 79 institutional investors and hedge funds held shares of Lyell Immunopharma. The most heavily invested institutionals were GSK plc ($46.56M), ARCH Venture Management LLC ($44.81M), MWG Caph Ltd ($31.03M), Vanguard Group Inc. ($12.65M), venBio Partners LLC ($10.39M), WuXi AppTec Co. Ltd. ($10.20M), and Almitas Capital LLC ($9.38M).Learn more on Lyell Immunopharma's institutional investors.

66.05% of Lyell Immunopharma's stock is owned by institutional investors. Learn more on LYEL's institutional investor holdings.

Of the 55 institutional investors that purchased Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($11.91M), Foresite Capital Management V LLC ($8.20M), venBio Partners LLC ($7.10M), ARCH Venture Management LLC ($2.76M), Almitas Capital LLC ($2.48M), GSK plc ($1.51M), and Renaissance Technologies LLC ($1.49M).

Institutional investors have bought a total of 6,559,136 shares in the last 24 months. This purchase volume represents approximately $134.10M in transactions.

Of the 21 institutional investors that sold Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: MWG Management Ltd. ($19.15M), Foresite Capital Management IV LLC ($15.21M), Orland Properties Ltd ($14.34M), Decheng Capital LLC ($11.31M), Foresite Capital Management V LLC ($7.73M), HSG Holding Ltd ($2.89M), and Canada Pension Plan Investment Board ($558.82K).

Institutional investors have sold a total of 73,060,645 shares in the last 24 months. This volume of shares sold represents approximately $651.96M in transactions.


Related Companies

Institutional ownership data for NASDAQ:LYEL is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/6/2026. New 13F filings are added each quarter as they're published.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel